MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
4.140
+0.010 (0.24%)
At close: Sep 18, 2026, 4:00 PM EDT
4.190
+0.050 (1.21%)
After-hours: Sep 18, 2026, 7:47 PM EDT
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $263.72 million as of September 18, 2026. Its market cap has increased by 172.72% in one year.
Market Cap
263.72M
Enterprise Value
125.51M
1-Year Change
172.72%
Ranking
Category
Stock Price
$4.14
ChartMarket Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $263.72M, a decrease of -56.07%. That is a compound annual growth rate of -6.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 263.70M | 159.04% |
| Dec 31, 2025 | 101.80M | -50.10% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
| Oct 10, 2013 | 600.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 278.81M |
| Greenwich LifeSciences | 273.01M |
| AC Immune | 271.44M |
| ProQR Therapeutics | 265.31M |
| Lyell Immunopharma | 264.66M |
| Lineage Cell Therapeutics | 257.97M |
| Bicycle Therapeutics | 257.57M |
| Foghorn Therapeutics | 252.68M |